glp 1 compounding fda is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compounded Semaglutide & Tirzepatide 2025:

This level of convenience has profound implications for long-term therapy

Look for "doctor-developed" backed by transparency and testing, not just a recommendation claim on the front of the box

Hyperpigmentation Reduction: Ingredients in the injection might target areas of hyperpigmentation, such as age spots or sun spots, and work to fade their appearance

doi: 10.3899/jrheum.2022-1135 82 HiramatsuYIsodaKKotaniTNakamuraEWadaYFujikiYet al

Meta-analyses have further confirmed that dual GLP-1/GIP receptor agonists are more effective than single GLP-1RAs in reversing liver fibrosis and reducing hepatic fat accumulation, suggesting a dose-dependent and receptor-combinatorial effect on liver outcomes (48)